- NCIt
- C8101
Loading cancer entity…
Loading cancer entity…
Clinical trials
1,164 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00045500 | UCN-01 and Prednisone in Treating Patients With Solid Tumors or Lymphoma | completed | Phase 1 | — | National Cancer Institute (NCI)NIH | 1 | Apr 30, 2015 | clinicaltrials |
| NCT00072111 | Anakinra in Treating Patients With Metastatic Cancer Expressing the Interleukin-1 Gene | completed | Phase 1 | — | National Cancer Institute (NCI)NIH | 1 | Apr 30, 2015 | clinicaltrials |
| NCT00003993 |
| Bryostatin 1 and Interleukin-2 in Treating Patients With Refractory Solid Tumors or Lymphoma |
| completed |
| Phase 1 |
| 24 |
| National Institute on Aging (NIA)NIH |
| 1 |
| Apr 29, 2015 |
| clinicaltrials |
| NCT00019344 | Flavopiridol in Treating Patients With Refractory Cancer | completed | Phase 1 | — | National Cancer Institute (NCI)NIH | 1 | Apr 29, 2015 | clinicaltrials |
| NCT00019357 | Interleukin-2 Plus Activated White Blood Cells in Treating Patients With Cancer That Has Not Responded to Chemotherapy or Radiation Therapy | completed | Phase 1 | — | National Cancer Institute (NCI)NIH | 1 | Apr 29, 2015 | clinicaltrials |
| NCT00019656 | Perifosine in Treating Patients With Refractory Solid Tumors or Hematologic Cancer | completed | Phase 1 | — | National Cancer Institute (NCI)NIH | 1 | Apr 29, 2015 | clinicaltrials |
| NCT00040729 | Genetic Study of Patients Previously Treated With Flavopiridol on Clinical Trial NCI-97-C-0171C | completed | — | — | National Cancer Institute (NCI)NIH | 1 | Apr 28, 2015 | clinicaltrials |
| NCT00343629 | Sulindac Capsules Compared With Sulindac Tablets in Healthy Volunteers | completed | N/A | 28 | Mayo ClinicOTHER | 1 | Apr 28, 2015 | clinicaltrials |
| NCT00217373 | Vaccine Therapy, GM-CSF, and Interferon Alfa-2b in Treating Patients With Locally Advanced or Metastatic Cancer That Expresses Carcinoembryonic Antigen (CEA) | completed | Phase 1 | 33 | National Cancer Institute (NCI)NIH | 1 | Apr 20, 2015 | clinicaltrials |
| NCT00255658 | Sorafenib and Temsirolimus in Treating Patients With Unresectable or Metastatic Solid Tumors | completed | Phase 1 | 40 | National Cancer Institute (NCI)NIH | 1 | Apr 15, 2015 | clinicaltrials |
| NCT00049400 | S0355 Ixabepilone in Treating Patients With Advanced Solid Tumors or Lymphomas and Liver Dysfunction | completed | Phase 1 | 78 | SWOG Cancer Research NetworkNETWORK | 1 | Apr 3, 2015 | clinicaltrials |
| NCT00951184 | Depression Screening in Patients Undergoing Radiation Therapy For Cancer | completed | — | 463 | Radiation Therapy Oncology GroupNETWORK | 1 | Mar 18, 2015 | clinicaltrials |
| NCT00352443 | S0528 Lapatinib and Everolimus in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma | completed | Phase 1 | 66 | SWOG Cancer Research NetworkNETWORK | 1 | Mar 6, 2015 | clinicaltrials |
| NCT00968643 | Spinal Cord Compression. ICORG 05-03, V6 | completed | Phase 3 | 126 | Cancer Trials IrelandNETWORK | 1 | Dec 31, 2014 | clinicaltrials |
| NCT01131234 | Gamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 20 | National Cancer Institute (NCI)NIH | 1 | Dec 23, 2014 | clinicaltrials |
| NCT01218620 | Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 17 | National Cancer Institute (NCI)NIH | 1 | Dec 23, 2014 | clinicaltrials |
| NCT00217477 | Paricalcitol and Gemcitabine in Treating Patients With Advanced Cancer | completed | Phase 1 | 34 | Roswell Park Cancer InstituteOTHER | 1 | Dec 9, 2014 | clinicaltrials |
| NCT00964275 | Standard Diagnostic Procedures With or Without Fludeoxyglucose F 18 Positron Emission Tomography in Finding Cancer in Patients With a Blood Clot in a Vein(MVTEP) | completed | N/A | 400 | University Hospital, BrestOTHER | 1 | Dec 8, 2014 | clinicaltrials |
| NCT00305799 | Hearing Loss and Dizziness in Patients Receiving Oxaliplatin for Solid Tumors | completed | — | 59 | Case Comprehensive Cancer CenterOTHER | 1 | Nov 24, 2014 | clinicaltrials |
| NCT00276575 | Bevacizumab, Everolimus, and Erlotinib in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 65 | Herbert Hurwitz, MDOTHER | 1 | Nov 19, 2014 | clinicaltrials |
| NCT01158274 | RO4929097 and Capecitabine in Treating Patients With Refractory Solid Tumors | completed | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 2 | Nov 7, 2014 | clinicaltrials |
| NCT01245205 | Akt Inhibitor MK2206 in Combination With Lapatinib Ditosylate in Patients With Advanced or Metastatic Solid Tumors or Breast Cancer | completed | Phase 1 | 28 | National Cancer Institute (NCI)NIH | 1 | Oct 23, 2014 | clinicaltrials |
| NCT00004258 | EMD 121974 in Treating Patients With Locally Advanced or Metastatic Cancer | completed | Phase 1 | 40 | Indiana UniversityOTHER | 1 | Sep 17, 2014 | clinicaltrials |
| NCT00057915 | Vaccine Therapy in Treating Patients With Refractory Stage IV Cancer | completed | Phase 1 | 4 | Duke UniversityOTHER | 1 | Sep 8, 2014 | clinicaltrials |
| NCT00275080 | Vorinostat and Decitabine in Treating Patients With Advanced Solid Tumors or Relapsed or Refractory Non-Hodgkin's Lymphoma, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Chronic Myelogenous Leukemia | completed | Phase 1 | 80 | National Cancer Institute (NCI)NIH | 1 | Aug 27, 2014 | clinicaltrials |
| NCT00567931 | 1-Methyl-D-Tryptophan in Treating Patients With Metastatic or Refractory Solid Tumors That Cannot Be Removed By Surgery | completed | Phase 1 | 52 | National Cancer Institute (NCI)NIH | 1 | Jul 24, 2014 | clinicaltrials |
| NCT01191216 | 1-Methyl-D-Tryptophan and Docetaxel in Treating Patients With Metastatic Solid Tumors | completed | Phase 1 | 27 | National Cancer Institute (NCI)NIH | 1 | Jul 24, 2014 | clinicaltrials |
| NCT00408655 | Temsirolimus, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 38 | National Cancer Institute (NCI)NIH | 1 | Jun 19, 2014 | clinicaltrials |
| NCT00058253 | Combination Chemotherapy in Treating Patients With Metastatic or Unresectable Solid Tumors | completed | Phase 1 | 80 | National Cancer Institute (NCI)NIH | 1 | Jun 17, 2014 | clinicaltrials |
| NCT00121264 | 17-AAG and Sorafenib in Treating Patients With Unresectable or Metastatic Solid Tumors | completed | Phase 1 | 54 | National Cancer Institute (NCI)NIH | 1 | Jun 17, 2014 | clinicaltrials |
| NCT00706290 | Brief CBT for Anxiety and Advanced Cancer | completed | Phase 2 | 49 | Massachusetts General HospitalOTHER | 1 | Jun 6, 2014 | clinicaltrials |
| NCT01198184 | Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 and Temsirolimus in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 18 | National Cancer Institute (NCI)NIH | 1 | May 30, 2014 | clinicaltrials |
| NCT01217450 | Selumetinib and Cetuximab in Treating Patients With Refractory Solid Tumors | completed | Phase 1 | 33 | National Cancer Institute (NCI)NIH | 1 | May 29, 2014 | clinicaltrials |
| NCT00415324 | Eribulin Mesylate and Cisplatin in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 36 | National Cancer Institute (NCI)NIH | 1 | May 20, 2014 | clinicaltrials |
| NCT00607880 | Study Comparing Two Types of Ports in Patients With Cancer Receiving Intravenous Chemotherapy | completed | Phase 2 | 100 | Mayo ClinicOTHER | 1 | May 9, 2014 | clinicaltrials |
| NCT00002923 | KRN5500 in Treating Patients With Metastatic Solid Tumors | completed | Phase 1 | 27 | Barbara Ann Karmanos Cancer InstituteOTHER | 1 | Apr 25, 2014 | clinicaltrials |
| NCT00028548 | XK469 in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 22 | Barbara Ann Karmanos Cancer InstituteOTHER | 1 | Apr 25, 2014 | clinicaltrials |
| NCT00004144 | Bryostatin 1 Plus Gemcitabine in Treating Patients With Advanced Cancer | completed | Phase 1 | 36 | Barbara Ann Karmanos Cancer InstituteOTHER | 1 | Apr 24, 2014 | clinicaltrials |
| NCT00003250 | Fenretinide in Treating Patients With Solid Tumors | completed | Phase 1 | 31 | Barbara Ann Karmanos Cancer InstituteOTHER | 1 | Apr 11, 2014 | clinicaltrials |
| NCT00112996 | Alpha-Lipoic Acid in Preventing Peripheral Neuropathy in Patients Receiving Chemotherapy for Cancer | completed | Phase 3 | 244 | M.D. Anderson Cancer CenterOTHER | 1 | Apr 8, 2014 | clinicaltrials |
| NCT00544596 | R-(-)-Gossypol Acetic Acid, Cisplatin, and Etoposide in Treating Patients With Advanced Solid Tumors or Extensive Stage Small Cell Lung Cancer | completed | Phase 1 | 27 | National Cancer Institute (NCI)NIH | 1 | Apr 2, 2014 | clinicaltrials |
| NCT01096355 | Gamma-Secretase Inhibitor RO4929097 in Treating Patients With Metastatic or Unresectable Solid Malignancies | completed | Phase 1 | 28 | National Cancer Institute (NCI)NIH | 1 | Apr 2, 2014 | clinicaltrials |
| NCT01243359 | Sunitinib Malate and Bevacizumab in Treating Patients With Kidney Cancer or Advanced Solid Malignancies | completed | Phase 1 | 6 | National Cancer Institute (NCI)NIH | 1 | Apr 2, 2014 | clinicaltrials |
| NCT00890747 | Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy | completed | Phase 1 | 42 | National Cancer Institute (NCI)NIH | 1 | Mar 17, 2014 | clinicaltrials |
| NCT00477607 | Alpha-Lipoic Acid in Preventing Hearing Loss in Cancer Patients Undergoing Treatment With Cisplatin | completed | Phase 2 / Phase 3 | 39 | US Department of Veterans AffairsFED | 1 | Mar 7, 2014 | clinicaltrials |
| NCT00003766 | O6-benzylguanine Followed by Surgery in Treating Patients With Solid Tumors That Can Be Removed During Surgery | completed | Phase 1 | 25 | University of ChicagoOTHER | 1 | Mar 6, 2014 | clinicaltrials |
| NCT00046917 | Combination Chemotherapy in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 13 | National Cancer Institute (NCI)NIH | 1 | Feb 24, 2014 | clinicaltrials |
| NCT00121290 | SJG-136 in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed By Surgery | completed | Phase 1 | 39 | National Cancer Institute (NCI)NIH | 1 | Feb 24, 2014 | clinicaltrials |
| NCT00227513 | Vorinostat and Bortezomib in Treating Patients With Metastatic or Unresectable Solid Tumors | completed | Phase 1 | 66 | National Cancer Institute (NCI)NIH | 1 | Feb 24, 2014 | clinicaltrials |
| NCT00324480 | Vorinostat and Alvocidib in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 60 | National Cancer Institute (NCI)NIH | 1 | Feb 24, 2014 | clinicaltrials |
Data updated 24 days agoSource updated Apr 30, 2015source: clinicaltrials